Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission: a Prospective Observational Study

NCT06799949 is registered in ClinicalTrials.gov with Kotoulas Serafeim-Chrysovalantis as lead sponsor.

NCT NCT06799949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06799949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission: a Prospective Observational Study
Lead sponsor
Kotoulas Serafeim-Chrysovalantis
Phase
Observational
Overall status
Active, not recruiting
Start date
January 14, 2025
Completion date
April 30, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparinization